New Appointments for Li Yanhong and Sun Piaoyang

Deep News03-27 14:51

On March 27, news emerged that the Hong Kong Special Administrative Region (SAR) government has announced the appointment of four new members to the Chief Executive's Advisory Group. Their terms will begin on April 1, 2026, and conclude on June 30, 2027.

The four new members are Baidu Group Co-Founder, Chairman, and CEO Li Yanhong; Chairman of HENGRUI PHARMA Sun Piaoyang; Founder and CEO of StarFive Semiconductor Technologies Co., Ltd. (StarFive Technology) Xu Tao; and Founder, Chairman, and CEO of Biren Technology Zhang Wen.

Hong Kong SAR Chief Executive John Lee Ka-chiu stated, "Since its establishment in 2023, the Chief Executive's Advisory Group has consistently provided valuable and constructive advice on the strategic development of Hong Kong. The newly appointed members are all industry leaders in cutting-edge fields such as hard tech and life sciences. Their participation will further broaden the professional scope of the Advisory Group. I look forward to the members continuing to offer suggestions on key issues, including how Hong Kong can consolidate and enhance its international competitiveness, better integrate into and serve the national development strategy, and deepen international exchanges and cooperation, particularly as Hong Kong proactively aligns with the national '16th Five-Year Plan' initiative, thereby creating a new phase of high-quality development for Hong Kong."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114111611?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 14:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114111611","market":"us","top_or_hot":-1,"title":"New Appointments for Li Yanhong and Sun Piaoyang","media":"Deep News","content":"<p>On March 27, news emerged that the Hong Kong Special Administrative Region (SAR) government has announced the appointment of four new members to the Chief Executive's Advisory Group. Their terms will begin on April 1, 2026, and conclude on June 30, 2027.</p>\n<p>The four new members are <name_en>Baidu</name_en> Group Co-Founder, Chairman, and CEO Li Yanhong; Chairman of <name_en>HENGRUI PHARMA</name_en> Sun Piaoyang; Founder and CEO of StarFive Semiconductor Technologies Co., Ltd. (StarFive Technology) Xu Tao; and Founder, Chairman, and CEO of Biren Technology Zhang Wen.</p>\n<p>Hong Kong SAR Chief Executive John Lee Ka-chiu stated, \"Since its establishment in 2023, the Chief Executive's Advisory Group has consistently provided valuable and constructive advice on the strategic development of Hong Kong. The newly appointed members are all industry leaders in cutting-edge fields such as hard tech and life sciences. Their participation will further broaden the professional scope of the Advisory Group. I look forward to the members continuing to offer suggestions on key issues, including how Hong Kong can consolidate and enhance its international competitiveness, better integrate into and serve the national development strategy, and deepen international exchanges and cooperation, particularly as Hong Kong proactively aligns with the national '16th Five-Year Plan' initiative, thereby creating a new phase of high-quality development for Hong Kong.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Appointments for Li Yanhong and Sun Piaoyang</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Appointments for Li Yanhong and Sun Piaoyang\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-03-27 14:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On March 27, news emerged that the Hong Kong Special Administrative Region (SAR) government has announced the appointment of four new members to the Chief Executive's Advisory Group. Their terms will begin on April 1, 2026, and conclude on June 30, 2027.</p>\n<p>The four new members are <name_en>Baidu</name_en> Group Co-Founder, Chairman, and CEO Li Yanhong; Chairman of <name_en>HENGRUI PHARMA</name_en> Sun Piaoyang; Founder and CEO of StarFive Semiconductor Technologies Co., Ltd. (StarFive Technology) Xu Tao; and Founder, Chairman, and CEO of Biren Technology Zhang Wen.</p>\n<p>Hong Kong SAR Chief Executive John Lee Ka-chiu stated, \"Since its establishment in 2023, the Chief Executive's Advisory Group has consistently provided valuable and constructive advice on the strategic development of Hong Kong. The newly appointed members are all industry leaders in cutting-edge fields such as hard tech and life sciences. Their participation will further broaden the professional scope of the Advisory Group. I look forward to the members continuing to offer suggestions on key issues, including how Hong Kong can consolidate and enhance its international competitiveness, better integrate into and serve the national development strategy, and deepen international exchanges and cooperation, particularly as Hong Kong proactively aligns with the national '16th Five-Year Plan' initiative, thereby creating a new phase of high-quality development for Hong Kong.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2097828714.EUR","symbol_name":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","start_time":0,"source_url":"","article_id":"1114111611","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114111611","pubTimestamp":1774594315,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On March 27, news emerged that the Hong Kong Special Administrative Region (SAR) government has announced the appointment of four new members to the Chief Executive's Advisory Group. Their terms will...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"89888":"百度集团-SWR","600276":"恒瑞医药","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","KBDU":"2倍做多BIDU ETF-KraneShares","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0229945570.USD":"TEMPLETON BRIC \"A\" (USD) ACC","BK4612":"AI芯片","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU1146622755.USD":"安本中国A股股票基金A Acc","BK4614":"Manus概念股","BK0183":"MSCI概念","BK4579":"人工智能","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK0028":"国家队","BK4574":"无人驾驶","LU1188198961.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) INC QV","LU0856984785.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"ACH\" (SGDHDG) ACC","BK1588":"回港中概股","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0359201612.USD":"贝莱德中国基金A2","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","BK0060":"抗癌","BK1615":"港股-互联网","BK4543":"AI","BK4531":"中概回港概念","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","BK1587":"次新股","LU0762541174.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM2\" (USD) INC","BK4514":"搜索引擎","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","BK0239":"医药制造","LU0630378692.HKD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (HKD) INC","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","LU0197773160.USD":"HSBC GIF ASIA PACIF EX JAPAN EQ HD \"AC\" ACC","09888":"百度集团-SW","LU0762540952.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AC\" (USD) ACC","BK4535":"淡马锡持仓","LU0463099449.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) ACC","LU0197773673.USD":"HSBC GIF ASIA PACIF EX JAPAN EQ HD \"AS\" (USD) INC","BK0188":"融资融券","LU0543330566.HKD":"TEMPLETON BRIC \"A\" (HKD) ACC","LU0163747925.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY A ACC","BK4548":"巴美列捷福持仓","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","BIDU":"百度","LU0173614495.USD":"富达中国焦点A","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","LU1048588211.SGD":"Blackrock Asian Dragon A2 SGD-H","LU2289578879.USD":"ALLIANZ CHINA A OPPORTUNITIES \"AT\" (USD) ACC","LU0244354667.USD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" ACC","LU0072462343.USD":"贝莱德亚洲巨龙基金","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","BK1095":"互动媒体与服务","LU1997245177.USD":"安联神洲A股基金","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","BK4077":"互动媒体与服务","LU1831875114.USD":"SCHRODER ISF ALL CHINA EQUITY \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK0196":"行业龙头","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","BK4587":"ChatGPT概念","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","BIDG":"2倍做多BIDU ETF-Leverage Shares","LU0821914370.USD":"贝莱德亚洲成长领袖A2","LU0287142896.SGD":"Fidelity China Focus A-SGD","BK1609":"ChatGPT概念","LU1997244956.HKD":"ALLIANZ CHINA A-SHARES \"AT\" (HKD) ACC A","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","BK4588":"碎股","BK0012":"证金概念","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK4552":"Archegos爆仓风波概念","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0823426308.USD":"法巴中国股票基金","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","LU1328615791.USD":"FULLERTON LUX FUNDS - ALL CHINA EQUITIES \"I\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0051755006.USD":"摩根大通中国A (dist)","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1575":"同股不同权","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","LU1255011170.USD":"JPM CHINA A-SHARE OPPORTUNITIES \"A\" (USD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","BK4602":"量子计算概念","LU0164865239.USD":"HSBC GIF CHINESE EQUITY \"AC\" (USD) ACC","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU0762542818.HKD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM\" (HKD) INC","LU2495084118.USD":"ALLIANZ CHINA A-SHARES \"ATH\" (USDHDG) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","BK4504":"桥水持仓","LU0228367735.SGD":"Eastspring Investments - Asian Equity Fund AS SGD","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","LU0823426480.USD":"法巴中国股票经典Dis","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","01276":"恒瑞医药","SG9999014674.SGD":"Nikko AM All China Equity A SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","SG9999002463.SGD":"LionGlobal China Growth SGD","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","BK4526":"热门中概股","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU0831093199.SGD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED INCOME \"AM3\" (SGDHDG) INC","LU0531971595.HKD":"HSBC GIF CHINESE EQUITY \"AD\" (HKD) INC","LU0052750758.USD":"富兰克林中国基金A Acc","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU0630378429.USD":"HSBC GIF ASIA PACIFIC EX JAPAN EQ HD \"AM2\" (USD) INC"},"translate_title":"李彦宏和孙飘扬的新任命","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"89888":1,"600276":1,"01276":1,"KBDU":1,"BIDU":1,"BIDG":1,"09888":1},"content_text":"On March 27, news emerged that the Hong Kong Special Administrative Region (SAR) government has announced the appointment of four new members to the Chief Executive's Advisory Group. Their terms will begin on April 1, 2026, and conclude on June 30, 2027.\nThe four new members are Baidu Group Co-Founder, Chairman, and CEO Li Yanhong; Chairman of HENGRUI PHARMA Sun Piaoyang; Founder and CEO of StarFive Semiconductor Technologies Co., Ltd. (StarFive Technology) Xu Tao; and Founder, Chairman, and CEO of Biren Technology Zhang Wen.\nHong Kong SAR Chief Executive John Lee Ka-chiu stated, \"Since its establishment in 2023, the Chief Executive's Advisory Group has consistently provided valuable and constructive advice on the strategic development of Hong Kong. The newly appointed members are all industry leaders in cutting-edge fields such as hard tech and life sciences. Their participation will further broaden the professional scope of the Advisory Group. I look forward to the members continuing to offer suggestions on key issues, including how Hong Kong can consolidate and enhance its international competitiveness, better integrate into and serve the national development strategy, and deepen international exchanges and cooperation, particularly as Hong Kong proactively aligns with the national '16th Five-Year Plan' initiative, thereby creating a new phase of high-quality development for Hong Kong.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114111611","isCrawlerRequest":true}